Actively Recruiting
Hyperbaric Oxygen Therapy for Optic Neuropathies
Led by Stanford University · Updated on 2025-05-25
60
Participants Needed
1
Research Sites
265 weeks
Total Duration
On this page
AI-Summary
What this Trial Is About
The purpose of the study is to evaluate the neuroprotective efficacy of hyperbaric oxygen for the treatment in patients with optic neuropathy.
CONDITIONS
Official Title
Hyperbaric Oxygen Therapy for Optic Neuropathies
Who Can Participate
Eligibility Criteria
You may qualify if you...
- Participant must be at least 18 years old
- Participant must be able to comply with all study requirements and complete all scheduled visits
- Participant must have clinical evidence of optic neuropathy
- Participant must understand and sign the informed consent; if vision is impaired, consent will be read aloud
You will not qualify if you...
- Participant unable to comply with study procedures or follow-up visits
- Evidence of corneal opacification or lack of optical clarity
- Participation in another clinical trial involving ocular or systemic drug administration within the last 3 months
- Participant is pregnant or lactating
- Physical or mental conditions increasing risk or interfering with study procedures
- Children and comatose patients
- Drug or alcohol abuse
- Prior hyperbaric oxygen treatment within the last 6 months
- Claustrophobia or inability to decompress properly
AI-Screening
AI-Powered Screening
Complete this quick 3-step screening to check your eligibility
Trial Site Locations
Total: 1 location
1
Byers Eye Institute
Palo Alto, California, United States, 94303
Actively Recruiting
Research Team
Z
Zac Wennberg Smith
CONTACT
How is the study designed?
Study Type
INTERVENTIONAL
Masking
SINGLE
Allocation
RANDOMIZED
Model
PARALLEL
Primary Purpose
TREATMENT
Number of Arms
3
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here